CXCR4 and cancer: In this regard, its covalent binding with the genotoxic antimetabolite Floxuridine (FdU) efficiently and selectively eliminates CXCR4+ cancer stem cells, thus preventing metastases and also inducing the regression of already stablished metastases with no toxicity in non-target tissues [35].